Background: Kawasaki disease (EK) is frequently identified in pediatric patients. It affects principally the coronary arteries, causing aneurysms, ischemic heart disease and sudden death. The opportune diagnosis and its early treatment avoid these complications. Our objective was to describe 17 cases with EK.
Clinical Cases: seventeen patients' files with EK were reviewed, obtaining information about age, sex, date of admission, clinical manifestations, laboratory results, complications and treatment.
Results: four patients presented coronary aneurysm. The average age was 37 months, with a range from 15 months to 11 years. There was a predominance of males, with relation 2.4 to 1.
Conclusions: the EK was not considerated initially; on post-mortem studies, affected coronary arteries were demonstrated. The EK treatment is intravenous gamma-globulin and aspirin and it must be established before the tenth day after the fever begins in order to avoid cardiac complications. Four cases developed AC remitted after 16 months. The EK diagnosis is predominantly clinical.
Download full-text PDF |
Source |
---|
Case Rep Cardiol
January 2025
Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA.
Anomalous aortic origin of a coronary artery is a rare congenital heart defect. The detection of anomalous coronary arteries is likely to increase with increased availability and application of cardiac computed tomography and magnetic resonance imaging. Once detected, the recommendation for surgical intervention on anomalous coronary arteries depends upon patient symptoms, the presence or absence of inducible ischemia on stress imaging, and high-risk anatomic features.
View Article and Find Full Text PDFCureus
December 2024
Nephrology, Ibn Sina Hospital, Rabat, Rabat, MAR.
Cryoglobulinemic vasculitis is a rare small-vessel vasculitis leading to multi-organ dysfunction, often associated with chronic infections like hepatitis C virus (HCV), and autoimmune disorders. Most cases involve mixed monoclonal or polyclonal immunoglobulins, presenting symptoms such as purpura, arthralgias, and weakness. Severe organ involvement, particularly cardiac, is rare but potentially life-threatening.
View Article and Find Full Text PDFClin Case Rep
January 2025
Cardiology Unit, Department of Internal Medicine College of Health Sciences, Addis Ababa University Addis Ababa Ethiopia.
Myocardial bridging is a common coronary anomaly. Although it is considered to be a benign condition, it can rarely be complicated by myocardial infarction. Clinicians should be suspicious of myocardial bridging as an etiology of myocardial infarction when other more common etiologies have been excluded.
View Article and Find Full Text PDFEur Heart J Case Rep
January 2025
Service de Cardiologie, Hôpital Trousseau, CHU de Tours, Avenue de la République, 37170 Chambray-Les-Tours, France.
Background: Myocardial bridging (MB) is considered a frequent and benign condition. However, some patients may experience symptoms. The recent ESC guidelines on sports participation provide guidance on the management of these symptomatic patients with MB but do not provide guidance in the presence of another cardiac pathology.
View Article and Find Full Text PDFEur Heart J Case Rep
January 2025
Cardiovascular Centre, Fukuoka City Hospital, 13-1 Yoshizukahon-machi, Hakata-ku, Fukuoka 812-0046, Japan.
Background: Radiofrequency ablation (RFA) procedures including cavo-tricuspid isthmus (CTI) ablation have proven to be safe and effective therapies for the treatment of many cardiac tachyarrhythmias. The incidence of coronary arterial injury (CAI) associated with RFA including CTI ablation is estimated to occur in <0.1% of patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!